Compliance certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30.06.2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ANG Lifesciences India Ltd has submitted a routine quarterly compliance certificate to BSE as required under SEBI's Depositories and Participants Regulations. The certificate, issued by the company's Registrar and Share Transfer Agent (Bigshare Services Private Limited), confirms that all physical share certificates received for dematerialization during the quarter ending 30 June 2025 were properly processed, verified, mutilated, and cancelled. It also confirms that the depository names were substituted in the company's register of members within the 15-day SEBI-mandated timeline. No new securities were issued or listed as part of this filing — it is purely a procedural confirmation.
No material impact on shareholders or stock price. This is a standard regulatory housekeeping filing required every quarter and does not signal any corporate action, fundraising, or change in business.